Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Small Cell Lung Cancer
NCT01713296Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Nov 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in small cell lung cancer (SCLC), sponsored by Hellenic Oncology Research Group. Started Nov 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01713296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01713296.